Avicanna To Bring Its CBD-Based Drugs To Latin America Via Chilean Pharma Partner
Cannabis-focused biopharmaceutical company Avicanna Inc. (TSX: AVCN) (OTCQX: AVCNF) (FSE: 0NN) revealed Friday that it has partnered with Chile's Knop Laboratorios S.A.
